Advancements in Pharmacotherapy for Noncancerous Manifestations of HPV

Area of Science:

• Dermatology
• Infectious Diseases
• Oncology

Background:

• Human papillomavirus (HPV) is a prevalent sexually transmitted infection.
• HPV infection leads to various cancers and noncancerous skin conditions like warts.
• Warts are a common reason for medical consultations.

Purpose of the Study:

• To review current therapeutic strategies for HPV infections.
• To categorize HPV treatments based on their mechanisms of action.
• To provide recent efficacy, safety, and regimen data for various treatment modalities.

Main Methods:

• Literature review of HPV treatment modalities.
• Categorization of treatments into destructive, virucidal, antimitotic, immunotherapy, and miscellaneous groups.
• Discussion of mechanism of action, efficacy, safety, and recommended regimens for each treatment.

Main Results:

• Multiple treatment categories exist for HPV, including destructive (e.g., cantharidin), virucidal (e.g., cidofovir), antimitotic (e.g., bleomycin), and immunotherapy (e.g., imiquimod).
• Each modality has a distinct mechanism of action, varying efficacy, and safety profiles.
• Challenges in treatment underscore the need for comprehensive understanding of available options.

Conclusions:

• Effective management of HPV-related conditions requires knowledge of diverse treatment approaches.
• The choice of therapy depends on the specific manifestation, patient factors, and treatment goals.
• Further research may refine existing treatments and explore novel therapeutic avenues for HPV.